Nationally Recognized Health Services Researcher and Entrepreneur Dr. Dena Bravata Joins Vivante Health’s Clinical Advisory Board
April 11, 2024 08:00 ET
|
Vivante Health
Dr. Dena Bravata Joins Vivante Health’s Clinical Advisory Board
Inflammatory Bowel Disease Expert and Harvard Medical School Faculty Dr. Hamed Khalili Joins Vivante Health’s Clinical Advisory Board
February 26, 2024 11:00 ET
|
Vivante Health
Inflammatory Bowel Disease Expert and Harvard Medical School Faculty Dr. Hamed Khalili Joins Vivante Health’s Clinical Advisory Board
Palisade Bio Announces Formation of Clinical Advisory Board with Appointments of Preeminent Key Opinion Leaders
February 08, 2024 08:05 ET
|
Palisade Bio, Inc.
Bruce Sands, MD, MS., Dr. Burrill B. Crohn Professor of Medicine, Icahn School of Medicine at Mount Sinai and System Chief, Division of Gastroenterology, Mount Sinai Health SystemFlorian Rieder, MD,...
Thermosome Appoints Dr. Frank Hermann, MD, as Chief Medical Officer and Adds Prof. Alessandro Gronchi, MD, to Clinical Advisory Board
December 05, 2023 04:00 ET
|
AKAMPION
- Two renowned oncology experts to support the development of Thermosome's clinical candidate THE001 Munich, Germany – December 05, 2023 – Thermosome, a drug development company specializing...
Retia Medical Announces Bernd Saugel has Joined the Clinical Advisory Board
June 01, 2021 09:00 ET
|
Retia Medical, LLC
VALHALLA, N.Y., June 01, 2021 (GLOBE NEWSWIRE) -- Retia Medical, an innovator in hemodynamic monitoring that helps clinicians guide care to prevent complications from high-risk surgeries such as...
Medical Leaders Join BioSig Clinical Advisory Board
November 28, 2018 08:00 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, Nov. 28, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
VBI Vaccines Announces Formation of New Scientific and Clinical Advisory Boards
September 26, 2018 08:00 ET
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Sept. 26, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ: VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and...